Quick Answer
Sonoma Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $2.79 (loss) per share for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed an increase of +73.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2013 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2013 to 2025), Sonoma Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 114.6%.
- Historical annual values: Fiscal year 2025: $2.79 (loss) per share | Fiscal year 2024: $10.63 (loss) per share | Fiscal year 2023: $1.52 (loss) per share | Fiscal year 2022: $1.92 (loss) per share | Fiscal year 2015: $0.85 (loss) per share | Fiscal year 2014: $0.54 per share | Fiscal year 2013: $1.30 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: